Page 90 - Read Online

Deivasigamani et al. Mini-invasive Surg 2023;7:9 https://dx.doi.org/10.20517/2574-1225.2022.99 Page 19 of 19

outcome? Diagn Interv Radiol 2013;19:501-7. DOI PubMed
83. Cazalas G, Jambon E, Coussy A, et al. Local recurrence and other oncologic outcomes after percutaneous image-guided tumor
ablations on stageT1b renal cell carcinoma: a systematic review and network meta-analysis. Int J Hyperthermia 2021;38:1295-303.
DOI PubMed
84. Atwell TD, Vlaminck JJ, Boorjian SA, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations,
safety, and local tumor control. J Vasc Interv Radiol 2015;26:792-9. DOI
85. Andrews JR, Atwell T, Schmit G, et al. Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal
masses. Eur Urol 2019;76:244-51. DOI
86. Hasegawa T, Yamanaka T, Gobara H, et al. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center
study. Jpn J Radiol 2018;36:551-8. DOI PubMed
87. Hebbadj S, Cazzato RL, Garnon J, et al. Safety Considerations and local tumor control following percutaneous image-guided
cryoablation of T1b renal tumors. Cardiovasc Intervent Radiol 2018;41:449-58. DOI PubMed
88. Gunn AJ, Joe WB, Salei A, et al. Percutaneous cryoablation of stage T1b renal cell carcinoma: safety, technical results, and clinical
outcomes. Cardiovasc Intervent Radiol 2019;42:970-8. DOI PubMed PMC
89. Grange R, Tradi F, Izaaryene J, et al. Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety,
functional and oncological outcomes. Int J Hyperthermia 2019;36:1065-71. DOI PubMed
90. Babaian KN, Okhunov Z, Juncal S, et al. Clinical outcomes of patients with nondiagnostic biopsy during cryoablation of small renal
masses. Urology 2015;85:605-9. DOI PubMed
91. Scoll BJ, Wong YN, Egleston BL, Kunkle DA, Saad IR, Uzzo RG. Age, tumor size and relative survival of patients with localized
renal cell carcinoma: a surveillance, epidemiology and end results analysis. J Urol 2009;181:506-11. DOI PubMed PMC
92. Powles T, Albiges L, Staehler M, et al. Updated european association of urology guidelines: recommendations for the treatment of
first-line metastatic clear cell renal cancer. Eur Urol 2018;73:311-5. DOI PubMed
93. Zondervan PJ, Wagstaff PG, Desai MM, et al. Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi
consensus project. World J Urol 2016;34:1657-65. DOI PubMed PMC
94. Jiménez JA, Zhang Z, Zhao J, et al. Surgical salvage of thermal ablation failures for renal cell carcinoma. J Urol 2016;195:594-600.
DOI PubMed
95. Baust JM, Santucci KL, Snyder K, et al. In Vitro Investigation of renal cell carcinoma response to combination sorafenib and
cryoablation treatment. clinical oncology and research 2022. Available from: https://www.sciencerepository.org/in-vitro-
investigation-of_COR-2022-1-101 [Last accessed on 28 Mar 2023].
96. Liu C, Cao F, Xing W, et al. Efficacy of cryoablation combined with sorafenib for the treatment of advanced renal cell carcinoma. Int
J Hyperthermia 2019;36:220-8. DOI PubMed
97. Gu CY, Wang JJ, Zhang HL, Shi GH, Ye DW. Survival in metastatic renal cell carcinoma patients treated with sunitinib with or
without cryoablation. Front Oncol 2021;11:762547. DOI
98. Campbell MT, Matin SF, Tam AL, et al. Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal
cell carcinoma. Nat Commun 2021;12:6375. DOI PubMed PMC
99. Lin M, Xu K, Liang S, et al. Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for
advanced renal cell cancer. Immunol Lett 2017;184:98-104. DOI PubMed
100. Harmon TS, Matteo J, Meyer TE, Kee-Sampson J. Pre-cryoablation embolization of renal tumors: decreasing probes and saving
loads. Cureus 2018;10:e3676. DOI PubMed PMC
101. Matteo J, Loper T, Hood P, Soule E, Kee-Sampson J, Martin JT. Embolization-induced renal tumor shrinkage followed by definitive
cryoablation. Cureus 2018;10:e3251. DOI PubMed PMC
102. Donato F, Ahrar K, Karam J, Matin S, Abdelsalam ME, Sabir S. Combined transarterial embolization and percutaneous image-guided
ablation for the treatment of T1B and central renal tumors in patients with high surgical risk. AJIR 2022;6:11. DOI